Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 6
2005 4
2006 6
2007 8
2008 2
2009 4
2010 17
2011 22
2012 33
2013 36
2014 41
2015 57
2016 66
2017 89
2018 86
2019 115
2020 161
2021 130
2022 120
2023 120
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

945 results

Results by year

Filters applied: . Clear all
Page 1
Correspondence.
Arrigo A, Aragona E, Bandello F. Arrigo A, et al. Among authors: bandello f. Retina. 2022 Oct 1;42(10):e46. doi: 10.1097/IAE.0000000000003502. Retina. 2022. PMID: 35413724 No abstract available.
Reply.
Sharma A, Gemmy Cheung CM, Arias-Barquet L, Ozdek S, Parachuri N, Kumar N, Hilely A, Zur D, Loewenstein A, Vella G, Bandello F, Querques G. Sharma A, et al. Among authors: bandello f. Retina. 2022 Mar 1;42(3):e20-e22. doi: 10.1097/IAE.0000000000003366. Retina. 2022. PMID: 34861660 No abstract available.
Towards a better understanding of non-exudative choroidal and macular neovascularization.
Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G. Sacconi R, et al. Among authors: bandello f. Prog Retin Eye Res. 2023 Jan;92:101113. doi: 10.1016/j.preteyeres.2022.101113. Epub 2022 Aug 13. Prog Retin Eye Res. 2023. PMID: 35970724 Review.
Reply.
Iuliano L, Corbelli E, Bandello F, Codenotti M. Iuliano L, et al. Among authors: bandello f. Retina. 2024 Mar 1;44(3):e24-e25. doi: 10.1097/IAE.0000000000004000. Retina. 2024. PMID: 37972969 No abstract available.
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Brown DM, Emanuelli A, Bandello F, Barranco JJE, Figueira J, Souied E, Wolf S, Gupta V, Ngah NF, Liew G, Tuli R, Tadayoni R, Dhoot D, Wang L, Bouillaud E, Wang Y, Kovacic L, Guerard N, Garweg JG. Brown DM, et al. Among authors: bandello f. Am J Ophthalmol. 2022 Jun;238:157-172. doi: 10.1016/j.ajo.2022.01.004. Epub 2022 Jan 14. Am J Ophthalmol. 2022. PMID: 35038415 Free article. Clinical Trial.
Reply.
Miere A, Sacconi R, Amoroso F, Capuano V, Jung C, Bandello F, Souied EH, Querques G. Miere A, et al. Among authors: bandello f. Retina. 2022 Jan 1;42(1):e11-e12. doi: 10.1097/IAE.0000000000003356. Retina. 2022. PMID: 34907130 No abstract available.
Correspondence.
Arrigo A, Pierro L, Marchese A, Bandello F. Arrigo A, et al. Among authors: bandello f. Retina. 2021 Feb 1;41(2):e19. doi: 10.1097/IAE.0000000000002929. Retina. 2021. PMID: 32740490 No abstract available.
Introduction.
Bandello F. Bandello F. Eur J Ophthalmol. 2020 Jan;30(1):5. doi: 10.1177/1120672119890409. Epub 2019 Nov 24. Eur J Ophthalmol. 2020. PMID: 31760779 No abstract available.
945 results